Animal Pneumoviruses: Molecular Genetics and Pathogenesis
Open accessThe DOI matches its Crossref record; 267 of the 267 references it cites were found in a registry or an index.
Abstract
SUMMARY: Pneumoviruses are single-stranded, negative-sense, nonsegmented RNA viruses of the family Paramyxoviridae, subfamily Pneumovirinae, and include pathogens that infect humans (respiratory syncytial virus and human metapneumovirus), domestic mammals (bovine, ovine, and caprine respiratory syncytial viruses), rodents (pneumonia virus of mice), and birds (avian metapneumovirus). Among the topics considered in this review are recent studies focused on the roles of the individual virus-encoded components in promoting virus replication as well as in altering and evading innate antiviral host defenses. Advances in the molecular technology of pneumoviruses and the emergence of recombinant pneumoviruses that are leading to improved virus-based vaccine formulations are also discussed. Since pneumovirus infection in natural hosts is associated with a profound inflammatory response that persists despite adequate antiviral therapy, we also review the recent experimental treatment strategies that have focused on combined antiviral, anti-inflammatory, and immunomodulatory approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 201–267 of 267
Gruber, W. C., Wilson, S. Z., Throop, B. J., & Wyde, P. R. (1987) · Pediatric Research · doi:10.1203/00006450-198703000-00013 · Cited by 62 · cited 1×
“Combination therapy with the antiviral ribavirin and systemically administered immunoglobulin has been tried with some success in the cotton rat model of hRSV infection (153), and one report of combined aerosolized ribavirin and systemic immunoglobulin treatment in bone marrow transplant recipients who developed hRSV…”
BackgroundChambers, P., Pringle, C. R., & Easton, A. J. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-7-1717 · Cited by 61
Self-citationSakurai, H., Williamson, R. A., Crowe, J. E., Beeler, J. A., Poignard, P., Bastidas, R. B., Chanock, R. M., & Burton, D. R. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2956-2962.1999 · Cited by 61
Woolums, A. R., Anderson, M. L., Gunther, R. A., Schelegle, E. S., Larochelle, D., Singer, R. S., Boyle, G. A., Friebertshauser, K. E., & Gershwin, L. J. (1999) · American Journal of Veterinary Research · doi:10.2460/ajvr.1999.60.04.473 · Cited by 60 · cited 1×
“toms of lower respiratory tract infection (287, 350, 367, 380).”
BackgroundZimmer, G., Rohn, M., McGregor, G. P., Schemann, M., Conzelmann, K.-K., & Herrler, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m306949200 · Cited by 59
Bonville, C. A., Easton, A. J., Rosenberg, H. F., & Domachowske, J. B. (2002) · Journal of Virology · doi:10.1128/jvi.77.2.1237-1244.2003 · Cited by 58 · cited 3×
“Dramatic clinical improvement was observed in response to systemic administration of ribavirin in combination with either neutralizing anti-MIP-1 antibody (27) or by pharmacologic blockade of the primary MIP-1 receptor CCR1 (29, 95).”
BackgroundSelf-citationCartee, T. L., & Wertz, G. W. (2001) · Journal of Virology · doi:10.1128/jvi.75.24.12188-12197.2001 · Cited by 58 · cited 1×
“various virus-encoded proteins (46, 188, 242, 339, 341), partic-”
Villanueva, N., Hardy, R. W., Asenjo, A., Yu, Q., & Wertz, G. W. (2000) · Microbiology · doi:10.1099/0022-1317-81-1-129 · Cited by 56 · cited 1×
“(366) demonstrated that most of the phosphorylation, occurring at residues 116, 117, 119, and 232, is not essential for transcription or replication.”
BackgroundPathogenesis of RSV lower respiratory tract infection: implications for vaccine development
Brandenburg, A. H., Neijens, H. J., & Osterhaus, A. D. M. E. (2001) · Vaccine · doi:10.1016/s0264-410x(00)00536-3 · Cited by 55 · cited 1×
“The postvaccination response has been characterized extensively, and the profound lymphocytic and eosinophilic inflammation observed has been attributed to an induced Th1-Th2 imbalance, with dominance of Th2 lymphocyte responses in this setting (32, 148, 180).”
BackgroundCrowe, J. E., Firestone, C.-Y., Crim, R. L., Beeler, J. A., Coelingh, K. L., Barbas, C. F., Burton, D. R., Chanock, R. M., & Murphy, B. R. (1998) · Virology · doi:10.1006/viro.1998.9462 · Cited by 54
Walsh, E. E., Sullender, W. M., & Falsey, A. R. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-3-479 · Cited by 54 · cited 1×
“Escape mutants have been created from hRSV grown in tissue culture in the presence of neutralizing monoclonal antibodies directed against the virus G or F proteins (241, 252, 253, 368).”
BackgroundTjørnehøj, K., Uttenthal, Å., Viuff, B. M., Larsen, L. E., Røntved, C. M., & Rønsholt, L. (2002) · Research in Veterinary Science · doi:10.1016/s0034-5288(02)00154-6 · Cited by 53 · cited 1×
“toms of lower respiratory tract infection (287, 350, 367, 380).”
BackgroundRespiratory syncytial virus prophylaxis?the story so far
Simões, E. A. F., & Groothuis, J. R. (2002) · Respiratory Medicine · doi:10.1053/rmed.2002.1296 · Cited by 52
Respiratory syncytial virus infection suppresses IFN-γproduction ofγδT cells
Aoyagi, M., Shimojo, N., Sekine, K., Nishimuta, T., & Kohno, Y. (2003) · Clinical & Experimental Immunology · doi:10.1046/j.1365-2249.2003.02062.x · Cited by 52
Larsen, L. E., Tjørnehøj, K., & Viuff, B. M. (2000) · Journal of Clinical Microbiology · doi:10.1128/jcm.38.11.4222-4227.2000 · Cited by 52 · cited 1×
“One study has documented sequence clustering based on geography (357), while yet another reports extensive sequence divergence in outbreaks distributed over time within a single herd (228).”
BackgroundKrempl, C. D., Murphy, B. R., & Collins, P. L. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.11931-11942.2002 · Cited by 49 · cited 1×
“The result is that genes proximal to the 3 leader region are represented in mRNA more abundantly than are those closer to the 5 end in a gradient of transcription (215).”
BackgroundRecognition of bovine respiratory syncytial virus proteins by bovine CD8+ T lymphocytes
Gaddum, R. M., Cook, R. S., Furze, J. M., Ellis, S. A., & Taylor, G. (2003) · Immunology · doi:10.1046/j.1365-2567.2003.01566.x · Cited by 48 · cited 1×
“ment of cellular immunity, specifically Th1 (gamma interferon) responses (102, 121, 125, 374).”
Efficacy of an inactivated respiratory syncytial virus vaccine in calves
Ellis, J., West, K. H., Konoby, C., Leard, T., Gallo, G. F., Conlon, J., & Fitzgerald, N. (2001) · Journal of the American Veterinary Medical Association · doi:10.2460/javma.2001.218.1973 · Cited by 46 · cited 2×
“There are several vaccine formulations in existence—modified live and inactivated, in both adjuvanted and nonadjuvanted forms (102, 374, 375)—and there is significant debate about the relative efficacy and modes of appropriate response.”
BackgroundSequence and in vitro expression of the M2 gene of turkey rhinotracheitis pneumovirus
Yu, Q., Davis, P. J., Brown, T. D. K., & Cavanagh, D. R. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-6-1355 · Cited by 46
Alvarez, R., Lwamba, H. M., Kapczynski, D. R., Njenga, M. K., & Seal, B. S. (2003) · Journal of Clinical Microbiology · doi:10.1128/jcm.41.4.1730-1735.2003 · Cited by 45
Gene expression in epithelial cells in response to pneumovirus infection
Domachowske, J. B., Bonville, C. A., & Rosenberg, H. F. (2001) · Respiratory Research · doi:10.1186/rr61 · Cited by 43 · cited 2×
“flammatory events has been best characterized using the PVM mouse model (92, 94), described in detail in “Pathogenesis of”
BackgroundMethodSelf-citationCytokines in severe respiratory syncytial virus bronchiolitis
Mobbs, K. J., Smyth, R. L., O'Hea, U., Ashby, D., Ritson, P. C., & Hart, C. A. (2002) · Pediatric Pulmonology · doi:10.1002/ppul.10101 · Cited by 43 · cited 1×
“tory secretions and in bronchoalveolar lavage samples from individuals infected with hRSV (1, 169, 182, 263).”
BackgroundGlucocorticoid Administration Accelerates Mortality of Pneumovirus‐Infected Mice
Domachowske, J. B., Bonville, C. A., Ali‐Ahmad, D., Dyer, K. D., Easton, A. J., & Rosenberg, H. F. (2001) · The Journal of Infectious Diseases · doi:10.1086/324664 · Cited by 43 · cited 1×
“flammatory events has been best characterized using the PVM mouse model (92, 94), described in detail in “Pathogenesis of”
MethodSelf-citationMartínez, I., & Melero, J. A. (2002) · Journal of General Virology · doi:10.1099/0022-1317-83-6-1445 · Cited by 42
Schmidt, U. G., Beyer, J., Polster, U., Gershwin, L. J., & Buchholz, U. J. (2002) · Journal of Virology · doi:10.1128/jvi.76.23.12355-12359.2002 · Cited by 42 · cited 1×
“This technology has already been applied to the development of the next generation of bRSV and hRSV vaccines (36, 317).”
MethodPneumoviruses: the Cell Surface of Lytically and Persistently Infected Cells
Parry, J. E., Shirodaria, P. V., & Pringle, C. R. (1979) · Journal of General Virology · doi:10.1099/0022-1317-44-2-479 · Cited by 41 · cited 1×
“In parallel with studies performed with other viruses, a progressive series of interactions between the glycoproteins and the M protein, which acts as a bridge with the nucleocapsids, results in the progeny virions budding from the surface of the cell in the form of filament structures (280).”
ResultZimmer, G., Conzelmann, K., & Herrler, G. (2002) · Journal of Virology · doi:10.1128/jvi.76.18.9218-9224.2002 · Cited by 41 · cited 2×
“ularly that of F and G proteins in hRSV infectivity and species specificity (130, 316, 347, 392), described in detail in “Cellular receptors” (above).”
BackgroundSequence analysis of the respiratory syncytial virus phosphoprotein gene
Satake, M., Elango, N., & Venkatesan, S. (1984) · Journal of Virology · doi:10.1128/jvi.52.3.991-994.1984 · Cited by 41 · cited 1×
“The P protein is an essential component of the replication and transcription complexes of the pneumoviruses (14, 225, 234, 314, 361).”
BackgroundDomachowske, J. B., Bonville, C. A., Gao, J., Murphy, P. M., Easton, A. J., & Rosenberg, H. F. (2000) · Cellular Immunology · doi:10.1006/cimm.2000.1730 · Cited by 41
Self-citationCharacteristics of a respiratory syncytial virus persistently infected macrophage-like culture
Silva, R. E. S., Tirado, R., & Gómez, B. (2002) · Virus Research · doi:10.1016/s0168-1702(01)00420-8 · Cited by 40 · cited 1×
“Other cells are susceptible to hRSV infection in culture, including the fibroblast cell line MRC-5, macrophage and macrophage-like cell lines (301, 313), and, for uptake if not outright infection, eosinophils (211).”
Backgroundvan der Sluijs, K. F., van Elden, L. J. R., Nijhuis, M., Schuurman, R., Florquin, S., Jansen, H. M., Lutter, R., & van der Poll, T. (2003) · Immunology Letters · doi:10.1016/s0165-2478(03)00138-x · Cited by 40 · cited 1×
“fluenza 1) yielded completely contradictory results (362).”
Risk of death from methicillin‐resistant Staphylococcus aureus bacteraemia: a meta‐analysis
Hurley, J. C. (2002) · The Medical Journal of Australia · doi:10.5694/j.1326-5377.2002.tb04355.x · Cited by 40
An ultrastructural study of the interaction of human eosinophils with respiratory syncytial virus
Kimpen, J. L. L., Garofalo, R. P., Welliver, C., Fujihara, K., & Ogra, P. L. (1996) · Pediatric Allergy and Immunology · doi:10.1111/j.1399-3038.1996.tb00105.x · Cited by 40 · cited 1×
“Other cells are susceptible to hRSV infection in culture, including the fibroblast cell line MRC-5, macrophage and macrophage-like cell lines (301, 313), and, for uptake if not outright infection, eosinophils (211).”
BackgroundElvander, M., Uttenthal, Å., Vilček, Š., Ballagi-Pord√°ny, A., Baule, C., & Bel√°k, S. (1998) · Journal of General Virology · doi:10.1099/0022-1317-79-12-2939 · Cited by 40 · cited 1×
“bRSV was first isolated and identified as a unique pathogen in the 1970s, and it is currently the closest known phylogenetic relative of hRSV (360), although there is no evidence for antigenic grouping into A/B strains (104).”
BackgroundReinhold, P., Becher, G., & Rothe, M. (2000) · American Journal of Veterinary Research · doi:10.2460/ajvr.2000.61.742 · Cited by 39 · cited 1×
“tions (302, 308), and elevations in levels of serum acute-phase response proteins (171).”
BackgroundHost Responses to Respiratory Virus Infection and Immunization
Crowe, J. E. (1999) · Current topics in microbiology and immunology · doi:10.1007/978-3-642-59951-4_10 · Cited by 39
Collins, P. L., & Wertz, G. W. (1985) · Virology · doi:10.1016/0042-6822(85)90384-8 · Cited by 38
Barr, J. N., Chambers, P., Harriott, P., Pringle, C. R., & Easton, A. J. (1994) · Journal of Virology · doi:10.1128/jvi.68.8.5330-5334.1994 · Cited by 35
Self-citationRøntved, C. M., Tjørnehøj, K., Viuff, B. M., Larsen, L. E., Godson, D. L., Rønsholt, L., & Alexandersen, S. (2000) · Veterinary Immunology and Immunopathology · doi:10.1016/s0165-2427(00)00214-2 · Cited by 35 · cited 1×
“tions (302, 308), and elevations in levels of serum acute-phase response proteins (171).”
BackgroundWorthington, K. J., Sargent, B. A., Davelaar, F. G., & Jones, R. C. (2003) · Vaccine · doi:10.1016/s0264-410x(02)00689-8 · Cited by 34 · cited 1×
“In various trials, several groups have demonstrated protection in response to immunization with high-passage virus (154, 283, 363, 381), with one report using highpassage virus from the Minnesota outbreak (APV/MN/turkey/ 1-a/97) together with the immunomodulatory agent S-28828 (299), an imidazoquinolinamine agent that…”
BackgroundKaraca, K., SHARMA, J. M., Tomai, M. A., & Miller, R. L. (1996) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.1996.16.327 · Cited by 34
Chemistry and Biochemistry of 2, 5-Oligoadenylate-Based Antisense Strategy
Adah, S. A., Bayly, S. F., Cramer, H., Silverman, R. H., & Torrence, P. F. (2001) · Current Medicinal Chemistry · doi:10.2174/0929867013372445 · Cited by 31
RAZA, M. W., BLACKWELL, C. C., ELTON, R. A., & WEIR, D. M. (2000) · Journal of Medical Microbiology · doi:10.1099/0022-1317-49-3-227 · Cited by 30 · cited 1×
“Other cells are susceptible to hRSV infection in culture, including the fibroblast cell line MRC-5, macrophage and macrophage-like cell lines (301, 313), and, for uptake if not outright infection, eosinophils (211).”
BackgroundBukreyev, A. A., Whitehead, S. S., Prussin, C., Murphy, B. R., & Collins, P. L. (2000) · Journal of Virology · doi:10.1128/jvi.74.15.7151-7157.2000 · Cited by 30 · cited 3×
“inclusion of immunomodulatory cytokines IL-2 (40) and granVOL.”
BackgroundInfluentialRussell, B., Prober, C. G., & Wang, E. E. L. (1997) · PEDIATRICS · doi:10.1542/peds.99.3.472 · Cited by 29
Munir, S., & Kapur, V. (2003) · Journal of Virology · doi:10.1128/jvi.77.8.4899-4910.2003 · Cited by 28 · cited 1×
“While the events promoting disease and tissue destruction are not yet understood at the molecular level, Munir and Kapur (266) have recently presented the results of a subtractive hybridization and gene microarray approach and have reported increased expression of transcripts encoding interferon response proteins and…”
BackgroundFogg, M. H., Parsons, K. R., Thomas, L. H., & Taylor, G. (2001) · Vaccine · doi:10.1016/s0264-410x(01)00030-5 · Cited by 28 · cited 1×
“ment of cellular immunity, specifically Th1 (gamma interferon) responses (102, 121, 125, 374).”
Neurovirulence of six different murine coronavirus JHMV variants for rats
Yutaka, M., Watanabe, R., & Taguchi, F. (1991) · Virus Research · doi:10.1016/0168-1702(91)90060-9 · Cited by 27
Reverse Genetics of TheParamyxoviridae
Marriott, A. C., & Easton, A. J. (1999) · Advances in virus research · doi:10.1016/s0065-3527(08)60354-1 · Cited by 25 · cited 1×
“ics, in studies of pneumovirus biology in general (68, 249) and”
BackgroundSelf-citationDuncan, R. B., & Potgieter, L. N. D. (1993) · Veterinary Microbiology · doi:10.1016/0378-1135(93)90032-3 · Cited by 24
Bonville, C. A., Mehta, P. A., Krilov, L. R., Rosenberg, H. F., & Domachowske, J. B. (2001) · Cellular Immunology · doi:10.1006/cimm.2001.1869 · Cited by 23 · cited 1×
“Also, as noted above, bRSV NS-1 and NS-2 proteins inhibit the production of beta interferon by reducing the activation of interferon-regulatory factor 3 (28) and bRSV NS-2 specifically is involved in interferon production in bovine nasal fibroblasts and bronchoalveolar macrophages (358).”
BackgroundSelf-citationWyde, P. R., Moore, D. K., Pimentel, D. M., Gilbert, B. E., Nimrod, R., & Panet, A. (1996) · Antiviral Research · doi:10.1016/0166-3542(95)06967-4 · Cited by 22 · cited 1×
“crude plant protein extracts (3), some forms of superoxide dismutase (384), an L-aspartate transcarbamoylase inhibitor”
BackgroundChambers, P., Matthews, D. A., Pringle, C. R., & Easton, A. J. (1991) · Virus Research · doi:10.1016/0168-1702(91)90023-o · Cited by 22 · cited 2×
“The intergenic regions of the pneumoviruses are variable in length and tolerate mutation and insertion of additional nucleotides (18, 42, 49, 361).”
BackgroundSelf-citationDiminished expression of an antiviral ribonuclease in response to pneumovirus infection in vivo
Moreau, J. M., Dyer, K. D., Bonville, C. A., Nitto, T., Vasquez, N. L., Easton, A. J., Domachowske, J. B., & Rosenberg, H. F. (2003) · Antiviral Research · doi:10.1016/s0166-3542(03)00111-6 · Cited by 21 · cited 1×
“Mouse PVM has similar target affinity and infects respiratory epithelial cells in vivo and the mouse epithelial cell line LA4 (265).”
BackgroundSelf-citationMcInnes, E. F., Collins, R. A., & Taylor, G. (1998) · Research in Veterinary Science · doi:10.1016/s0034-5288(98)90013-3 · Cited by 20 · cited 1×
“feron in cells drained from pulmonary lymph (139, 214) and in peripheral blood mononuclear cells (257), detection of tumor”
BackgroundHuman metapneumovirus, a newly emerging respiratory virus
Kahn, J. S. (2003) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000091347.27554.ff · Cited by 19
Tang, R. S., Nguyen, N., Zhou, H., & Jin, H. (2002) · Virology · doi:10.1006/viro.2002.1596 · Cited by 19 · cited 1×
“various virus-encoded proteins (46, 188, 242, 339, 341), partic-”
Chambers, P., Pringle, C. R., & Easton, A. J. (1991) · Journal of General Virology · doi:10.1099/0022-1317-72-10-2545 · Cited by 18
Self-citationCharacterization of avian metapneumoviruses isolated in the USA
Lwamba, H. M., Bennett, R. S., Lauer, D. C., Halvorson, D. A., & Njenga, M. K. (2002) · Animal Health Research Reviews · doi:10.1079/ahrr200243 · Cited by 17
Sudo, K., Konno, K., Watanabe, W., Shigeta, S., & Yokota, T. (2001) · Microbiology and Immunology · doi:10.1111/j.1348-0421.2001.tb02654.x · Cited by 15 · cited 1×
“tein, thereby resulting in decreased infectivity (333).”
Barr, J. N., & Easton, A. J. (1995) · Virus Research · doi:10.1016/0168-1702(95)00090-9 · Cited by 15
Self-citationKnott, I., Weynants, V. E., Walravens, K., van der Poel, W. H. M., Kramps, J. A., & Letesson, J. (1998) · Archives of Virology · doi:10.1007/s007050050360 · Cited by 14 · cited 1×
“feron in cells drained from pulmonary lymph (139, 214) and in peripheral blood mononuclear cells (257), detection of tumor”
BackgroundCaravokyri, C., Zajac, A. J., & Pringle, C. R. (1992) · Journal of General Virology · doi:10.1099/0022-1317-73-4-865 · Cited by 12 · cited 1×
“In addition to the full-length sequence, the P gene of hRSV encodes an mRNA for an additional, short polypeptide of unknown function (45).”
BackgroundKhoshoo, V., Ross, G., & Edell, D. S. (2002) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-200205000-00035 · Cited by 8 · cited 1×
“Studies of the outcome of bronchiolitis during infancy have included studies that evaluated the effects of ribavirin therapy during acute illness on the long-term sequelae of recurrent wheezing during childhood (101, 132, 208, 240, 256, 310), with promising results.”
BackgroundSynergistic action of cytokines and purified respiratory syncytial virus in nitric oxide induction
Hacking, D., Rockett, K., Hull, J., & Kwiatkowski, D. P. (2002) · Journal of Leukocyte Biology · doi:10.1189/jlb.71.4.729 · Cited by 5 · cited 2×
“infection in vitro include the production of inducible nitric oxide synthase and nitric oxide (155, 201, 356) beta interferon,”
BackgroundShaping animal body plans in development and evolution by modulation of Hox expression patterns
(1998) · doi:10.1002/(sici)1521-1878(199802)20:2 · cited 1×
“GAGs clearly play a significant role in the infectivity of wild-type virus, and the recent identification of protein binding domains with high affinity for specific GAGs may be of some help in this endeavor (174).”
Background
Cited by
Inhibition of respiratory viruses by nasally administered siRNA
Bitko, V., Musiyenko, A., Shulyayeva, O., & Barik, S. (2005) · Nature Medicine · doi:10.1038/nm1164 · Cited by 725
Immune Responses and Disease Enhancement during Respiratory Syncytial Virus Infection
Openshaw, P. J. M., & Tregoning, J. S. (2005) · Clinical Microbiology Reviews · doi:10.1128/cmr.18.3.541-555.2005 · Cited by 292
Metadata
- Authors
- Easton, A. J., Domachowske, J. B., & Rosenberg, H. F.
- Venue
- Clinical Microbiology Reviews
- Publisher
- American Society for Microbiology
- Published
- 2004-04
- Volume
- 17
- Issue
- 2
- Pages
- 390-412
- ISSN
- 0893-8512 (ISSN-L)
- 1098-6618
- OpenAlex
- W2135270248
- Cited by
- 212
- References
- 267
- FWCI
- 9.90
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.